Innovita Biological Technology Co. Ltd. A Capital Reinvestment Ratio
Innovita Biological Technology Co. Ltd. A capital reinvestment ratio. Innovita Biological Technology Co. Ltd. A (688253) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥193.13 Million) in capital expenditures (CN¥31.13 Million). Check 688253 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Innovita Biological Technology Co. Ltd. A (2020–2025)
Capital reinvestment ratio of Innovita Biological Technology Co. Ltd. A from 2020 to 2025. This chart tracks Innovita Biological Technology Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. Also explore net asset growth rate of Innovita Biological Technology Co. Ltd. to track the company's year-over-year net asset growth rate.
Innovita Biological Technology Co. Ltd. A Capital Reinvestment Ratio by Year (2020–2025)
Innovita Biological Technology Co. Ltd. A capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see 688253 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥193.13 Million | CN¥31.13 Million | ▲ +36.2% |
| 2024 | 0.12x | CN¥305.46 Million | CN¥36.16 Million | ▲ +81.3% |
| 2023 | 0.07x | CN¥259.85 Million | CN¥16.97 Million | ▼ -85.7% |
| 2022 | 0.46x | CN¥126.43 Million | CN¥57.71 Million | ▼ -23.9% |
| 2021 | 0.60x | CN¥106.27 Million | CN¥63.75 Million | ▲ +400.3% |
| 2020 | 0.12x | CN¥639.82 Million | CN¥76.71 Million | — |